Industry: Health Care – Biotechnology: Pharmaceutical Preparations
Stock Symbol: IBO – AMEX
Animal Usage: Animal Testing
Impact BioMedical Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing to assess a product’s safety profile.
Supporting Evidence:
The company confirms in the following report that they use animals for product testing.
“The result of this one-year program will be looking at two therapeutic drugs that have been evaluated for in-vitro efficacy against Pancreatic, Lung, Breast, and Prostate Cancer; in-vivo efficacy against Pancreatic Cancer in an animal model; in-vivo efficacy against Pancreatic Cancer-induced pain in an animal model; and in-vivo Pharmacokinetic and toxicity in animals to include vital organ and blood plasma concentrations after administration, major cytokine activity, renal function, blood chemistry/hematology, cellular morphology, Mitotic index, and Maximum Tolerated Dose.” (Page 22) Read the full document
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. Impact BioMedical Inc. operates as a subsidiary of DSS, Inc.
Company Website: https://www.impactbiomedinc.com